Aplastic anemia: dramatic increase in hematologic response with eltrombopag

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Addition of eltrombopag (Promacta) to horse antithymocyte globulin (Atgam, ATG) and cyclosporine in patients with previously untreated severe aplastic anemia resulted in dramatic increases in hematologic response compared with historical outcomes.

Why this matters

  • There have b...